Home › Therapeutic areas › Neurology › Spinal Cord Injury
Spinal Cord Injury (2 companies)
Companies with an active program in Spinal Cord Injury.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics | MetabolicNeurology+1 Rare | 1 | Phase 2 | $258M | 12 |
| NGEN | NervGen Pharma | Neurology | 2 | Phase 3 | $143M | 3 |
No companies match.